Obesity and diabetes

How does obesity accelerate the beta cell failure that’s characteristic of type 2 diabetes? And why does NAFLD advance to liver fibrosis or NASH in some people? These are among the questions that Professor John Wilding would like to see answered in the near future.

For more on this topic, enrol on the following modules:

• Understanding the causes of type 2 diabetes − and how to achieve remission
• Obesity and the pathogenesis and outcomes of type 2 diabetes

For more from Professor John Wilding, enrol on the following courses:

• Cardiovascular health and diabetes
• SGLT-2 inhibitors